Drug shortage
Oxaliplatin Injection · Sandoz Inc.
FDA drug shortage · To Be Discontinued · updated Oct 20, 2025
Key facts
| Generic name | Oxaliplatin Injection |
|---|---|
| Company | Sandoz Inc. |
| Presentation | Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Oncology |
| Package NDCs | 0781-3315-70 |
| First posted | Oct 20, 2025 |
| Last updated | Oct 20, 2025 |
| Discontinued | Oct 20, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: